Epimedin A inhibits the PI3K/AKT/NF-κB signalling axis and osteoclast differentiation by negatively regulating TRAF6 expression

Abstract Background Epimedin A (EA) has been shown to suppress extensive osteoclastogenesis and bone resorption, but the effects of EA remain incompletely understood. The aim of our study was to investigate the effects of EA on osteoclastogenesis and bone resorption to explore the corresponding sign...

Full description

Bibliographic Details
Published in:Molecular Medicine
Main Authors: Jun Li, Jia J. Wei, Cen H. Wu, Tao Zou, Hong Zhao, Tian Q. Huo, Cheng J. Wei, Ting Yang
Format: Article
Language:English
Published: BMC 2024-08-01
Subjects:
Epimedin A
Osteoporosis
Osteoclastogenesis
TRAF6
PI3K/AKT/NF-κB signalling pathway
Online Access:https://doi.org/10.1186/s10020-024-00893-w

Internet

https://doi.org/10.1186/s10020-024-00893-w

Similar Items